Published on September 12, 2013 at 8:28 AM
"McGill University is proud to be a founding partner of IPAC, and we thank P3G, CGP, and Professor Knoppers for their leadership on this important initiative," said Dr. Rose Goldstein, McGill's Vice-Principal (Research and International Relations). "International partnerships and interdisciplinary research are fundamental to McGill's research enterprise. We believe that by helping world-class researchers to work more collaboratively, regardless of discipline or country, we ensure that the strongest ideas will be applied to the transformative field of genomics."
IPAC, a P3G initiative
Created in 2007 and funded by Genome Canada, G-nome Qu-bec and the Canadian Institutes of Health Research, P3G is an international not-for-profit organization based in Montr-al. It works with experts from more than 50 countries, providing them with the support they need to conduct high-quality, large-scale research projects. From 2007 to 2012, the goal of P3G was to help build large population cohorts. But as Professor Bartha Maria Knoppers explains: "In its Phase II (2013-2018), the focus of P3G is to ensure access and use of both genomic research and clinical databases, so as to move towards genomic medicine. The launch of the IPAC is an important part of this phase. In addition, P3G is built on a world-class team with unique expertise, making IPAC a logical extension of this international consortium."
P3G is a partner organization in the development of the global alliance to enable the responsible sharing of genomic and clinical data. It is committed to fostering and facilitating global data sharing through international interoperability mechanisms.
Source: Génome Québec